Similar Articles
Diagnostic Sensitivity of Different Applications of Pathergy Test for Behçet’s Disease
İncilay KALAY YILDIZHAN, Ayse BOYVAT
DOI: 10.5606/ArchRheumatol.2020.7380
Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis
Kemal Erol, Ragıp Ertaş
DOI: 10.46497/ArchRheumatol.2020.7541
Assessment of the Clinical Effects of Aquatic-based Exercises in the Treatment of Children With Juvenile Dermatomyositis: A 2x2 Controlled-Crossover Trial
Ahmed SAMHAN, Nermeen MOHAMED, Ragab ELNAGGAR, Waleed MAHMOUD
DOI: 10.5606/ArchRheumatol.2020.7548
The Validity and Sensitivity of Rheumatoid Arthritis Pain Scale on a Different Ethnic Group From Indian Rheumatoid Arthritis Patients
Harpreet SINGH, Sameer ARORA, Vikram TANWAR, Ankit KALRA, Gagandeep SUKHIJA, Nikhil GOVIL
DOI: 10.5606/ArchRheumatol.2020.7348
Serum Pyridinoline is Associated With Radiographic Joint Erosions in Rheumatoid Arthritis
Abu Mansor Matardiah NOR HASHIMAH, Rajalingham SAKTHISWARY, Syahrul Sazliyana SHAHARIR, Asrul WAHAB
DOI: 10.5606/ArchRheumatol.2019.7243
The Anti-Rheumatoid Activity of Niclosamide in Collagen-Induced Arthritis in Rats
Ali AL-GAREEB, Faiq GORIAL, Ahmed MAHMOOD
DOI: 10.5606/ArchRheumatol.2019.7100
Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial
Toong-Hua LIANG, Chyou-Shen LEE, Shinn-Shing LEE, Chien-Sheng WU, Kun-Hung CHEN, Ping-Ning HSU, Hsiao-Yi LIN
DOI: 10.46497/ArchRheumatol.2020.7464
Decreased Bilirubin is Associated With Disease Activity of Primary Sjögren's Syndrome
Jing XIE, Zhencheng ZHANG, Yan LIANG, Zaixing YANG
DOI: 10.46497/ArchRheumatol.2020.7633
The Relationship Between Serum Angiogenic Factor Levels and Disease Activity in Rheumatoid Arthritis
Zahide ASLANALP, Canan TIKIZ, Aslıhan ULUSOY, Şebnem ORGUC, Aysun BİLGİ YEDEKCİ, Cevval ULMAN
DOI: 10.46497/ArchRheumatol.2020.7416
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry
Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA
DOI: 10.46497/ArchRheumatol.2020.7499
Self-Reported Medication Adherence in Patients With Ankylosing Spondylitis: The Role of Illness Perception and Medication Beliefs
Sena TOLU, Aylin REZVANİ, İlhan KARACAN, Derya BUGDAYCI, Habib Can KÜÇÜK, Ömer Faruk BUCAK, Teoman AYDIN
DOI: 10.46497/ArchRheumatol.2020.7732
The Correlations Between Disease Specific Quality of Life, Short Form-36 and Clinical Variables in Patients With Ankylosing Spondylitis
Hakan ALKAN, Necmettin YILDIZ, Füsun ARDIÇ
DOI: 10.46497/ArchRheumatol.2020.7750
Does Abatacept Induce Testicular Toxicity?
Sultan AL-MOGAIREN
DOI: 10.46497/ArchRheumatol.2020.7164
Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life
İsmihan SUNAR, Şebnem ATAMAN
DOI: 10.46497/ArchRheumatol.2020.7456
Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?
Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7579
Obesity and Remission Rates in Japanese Patients With Rheumatoid Arthritis Requiring Anti-Tumor Necrosis Factor Alpha Therapy
Kenji YAMAZAKI, Etsuji SUZUKI, Ryuhei ISHIHARA, Toshiaki MIYAMOTO
DOI: 10.46497/ArchRheumatol.2020.7852
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7868
Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs
Yaşar KESKİN, Kemal NAS, Erkan KILIÇ, Betul SARGIN, Sevtap ACER KASMAN, Hakan ALKAN, Nilay ŞAHİN, Gizem CENGİZ, Nihan CUZDAN, İlknur ALBAYRAK GEZER, Dilek KESKİN, Cevriye MÜLKOĞLU, Hatice RESORLU, Şebnem ATAMAN, Ajda BAL, Mehmet Tuncay DURUOZ, Okan KÜÇÜKAKKAS, Ozan Volkan YURDAKUL, Meltem ALKAN MELİKOĞLU, Yıldıray AYDIN, F. Figen AYHAN, Hatice BODUR, Mustafa ÇALIŞ, Erhan ÇAPKIN, Gül DEVRİMSEL, Kevser GÖK, Sami HİZMETLİ, Ayhan KAMANLI, Hilal ECESOY, Öznur KUTLUK, Nesrin ŞEN, Ömer Faruk ŞENDUR, İbrahim TEKEOĞLU, Sena TOLU, Murat TOPRAK, Tiraje TUNCER
DOI: 10.46497/ArchRheumatol.2021.7874
Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study
Takeshi MOCHIZUKI, Koichiro YANO, Katsunori IKARI, Ryo HIROSHIMA, Mina ISHIBASHI, Ken OKAZAKI
DOI: 10.46497/ArchRheumatol.2021.7727
Knowledge of cardiovascular disease risk in rheumatoid arthritis patients before and after educational intervention from a Southeast Asia country: Malaysia
Boon Ching TEOH, Syed Azhar SYED SULAIMAN, Bee Eng TAN
DOI: 10.46497/ArchRheumatol.2021.7726